The anti-birth drug is now "available for use by any women of reproductive age in Europe"

A brand of the morning-after pill has been officially licensed for use by girls under the age of sixteen.

The license for 'EllaOne' has been changed by the European medicines agency, and now this anti-birth drug is "available for use by any women of reproductive age in Europe." [Guardian, 15 June] 'EllaOne' will be available from any pharmacist that stocks it. 'EllaOne' is effective five days after intercourse and the recommended retail price is £34.95.

Girls wanting to buy 'EllaOne' will be asked questions assessing whether they are 'Gillick competent', meaning that they understand the consequences of taking the morning after pill. SPUC has released an official statement, which can be read here.

Other stories:

• Abortion due to disability on the rise [Catholic Herald, 16 June]
• Couple risk prison after adopting baby who would have been aborted [Daily Mail, 12 June]
• Parents criticise disability as reason for abortion [Christian Institute ,June 11]
• Mumsnet backs 'illegal' DIY abortions [Telegraph, 11 June]
• 51% of abortions are medical abortions [Medical News Today, 9 June]
• Abortion now more common amongst women in their early 30s than teenagers [Daily Mail, 9 June]
• British Prime Minister states opposition to legalised assisted suicide [Care Not Killing, 10 June]
• Vulnerable people threatened by Labour MP's suicide proposal [SPUC, 9 June]
• Baby boy discovered alive and well after doctors had declared him dead [Sunday World, 9 June]